About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Arizona | 16,738 Studies Near You

Clinical TrialsArizona

Clinical Trials in Arizona

Discover 16,738 clinical trials near Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1021-1040 of 16,738 trials

CompletedIrbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)The purpose of this clinical research study is to learn if Irbesartan is superior to placebo in reducing mortality and cardiovascular morbidity in subjects with heart failure with…NCT00095238·Birmingham, Alabama and 228 others

Find Trials by Condition in Arizona

Breast Cancerin Arizona Lung Cancerin Arizona Prostate Cancerin Arizona Colorectal Cancerin Arizona Melanomain Arizona Leukemiain Arizona Lymphomain Arizona Pancreatic Cancerin Arizona Ovarian Cancerin Arizona Brain Cancerin Arizona Diabetes

Data from ClinicalTrials.govTerms

UnknownCarbonic Anhydrase Inhibitors and Carbonation: A Novel Approach to Reduce Soda ConsumptionAcetazolamide is a drug that is approved by the FDA for treating various conditions like epilepsy, altitude sickness, and glaucoma.NCT06110078·Phoenix, Arizona

CompletedEvaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With BronchiectasisOver the 70-day study period, eligible patients visited the study clinic every 2 weeks (total of 6 visits) and received a 28-day course of aztreonam for inhalation solution (AZLI).NCT00805025·Birmingham, Alabama and 23 others

CompletedImplementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)The purpose of this study is to determine whether a multidisciplinary digital clinic will improve health outcomes, reduce costs, increase access, and improve provider satisfaction.NCT06319222·Scottsdale, Arizona and 1 other

TerminatedAn Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)Primary Objectives: 1.NCT05626751·Phoenix, Arizona and 64 others

CompletedA Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With DupilumabThe study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) previously treated with Dupilumab.NCT05369403·Montgomery, Alabama and 36 others

WithdrawnStudy to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/sThe objective of this phase III study is to evaluate the efficacy, systemic safety and local tolerability of P-3073 (calcipotriene 0.005%) nail solution in patients with mild to…NCT03079973·Birmingham, Alabama and 57 others

CompletedEfficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic VirusThis is a randomized, double-blind, double-dummy, 48-week, comparative study.NCT01338883·Birmingham, Alabama and 47 others

CompletedEfficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal AtrophyThis study is intended to establish the lowest effective dose of EstroGel® for the treatment of vasomotor symptoms associated with menopause.NCT00160173·Birmingham, Alabama and 108 others

CompletedAAB-001 in Patients With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to assess the safety and tolerability of multiple doses of AAB-001 passive immunization in patients with mild to moderate Alzheimer's disease (AD).NCT00112073·Sun City, Arizona and 25 others

CompletedHormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate CancerRATIONALE: Hormones can stimulate the production of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00004054·Birmingham, Alabama and 53 others

TerminatedA Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus ErythematosusThe primary objective of this study is to evaluate the long term safety and tolerability of repeated administration of subcutaneous (SC) CEP-33457 for injection every 4 weeks over…NCT01240694·Birmingham, Alabama and 84 others

CompletedPlasma and Intrapulmonary Concentrations Study of WCK 5222This is a Phase 1, multiple dose, open-label pharmacokinetic study in healthy adult male and female subjects.NCT03630094·Phoenix, Arizona

CompletedTesting the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of RecurringThis is a phase I-II trial to find the safety and activity of adding a new drug (neraparib) to the usual treatment (radiation combined with male hormone deprivation therapy) in…NCT04037254·Gilbert, Arizona and 94 others

CompletedCognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older VolunteersThe purpose of this study is to explore the possible cognitive effects of oxybutynin tablets and oxybutynin gel.NCT00752141·Tucson, Arizona and 5 others

TerminatedA Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.This study will evaluate the efficacy, safety, durability, and pharmacokinetics of KSI-301 administered at 12, 16 and 20 weeks intervals as specified in the protocol, compared…NCT04049266·Phoenix, Arizona and 74 others

CompletedStudy of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial CancersPhase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-002 given intravenously every 3 weeks.NCT03748186·Tucson, Arizona and 26 others

Active not recruitingEvaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent IohexolThis trial studies how well iohexol works in helping doctors calculate the dose of carboplatin given to patients with cancer.NCT03997370·Tucson, Arizona and 188 others

CompletedSafety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric HyperoxaluriaThis Phase 1a/b, first-in-human, multiple dose-escalation, randomized, double-blinded, placebo-controlled study is evaluating SYNB8802 in healthy volunteers (HV) and subjects…NCT04629170·Tucson, Arizona and 3 others

Active not recruitingErlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerThis randomized phase II trial studies how well giving erlotinib hydrochloride and cabozantinib-s-malate alone or in combination works as second or third line therapy in treating…NCT01708954·Scottsdale, Arizona and 355 others

PreviousPage 52 of 837Next

in Arizona

Heart Diseasein Arizona